GEN Exclusives

More »

GEN News Highlights

More »
Apr 30, 2013

NextBio, Sanofi Team Up to Incorporate Omics Data into R&D

  • NextBio and Sanofi are teaming up to incorporate omics and clinical data into the latter firm’s drug R&D program, Translational Medicine for Patients. Through this partnership, NextBio will provide Sanofi's clinical trials and hospital platforms with its platform, which enables users to aggregate and interpret large quantitities of molecular and other life sciences data, allowing them to access and utilize patient data in real time. Financial terms of the agreement were not disclosed.

    "Sanofi has long used NextBio as an important component of the company's preclinical research programs," Saeid Akhtari, NextBio president and CEO, said in a statement. "The new translational medicine partnership with NextBio, with its Big Data Genomics capabilities, will enable Sanofi to implement patient-centered approaches across all stages of translational and clinical research in several major therapeutic areas, including oncology and diabetes."


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?